Target Price | $12.50 |
Price | $3.48 |
Potential |
259.20%
register free of charge
|
Number of Estimates | 4 |
4 Analysts have issued a price target Relmada Therapeutics Inc 2025 .
The average Relmada Therapeutics Inc target price is $12.50.
This is
259.20%
register free of charge
$25.00
618.39%
register free of charge
$2.00
42.53%
register free of charge
|
|
A rating was issued by 4 analysts: 3 Analysts recommend Relmada Therapeutics Inc to buy, 0 to hold and 1 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Relmada Therapeutics Inc stock has an average upside potential 2025 of
259.20%
register free of charge
|
Dec '23 |
2024 Estimates |
|
---|---|---|
Earnings Per Share $ | -3.28 | -2.70 |
38.11% | 17.68% | |
P/E | negative |
2 Analysts have issued a Relmada Therapeutics Inc forecast for earnings per share. The average Relmada Therapeutics Inc <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Relmada Therapeutics Inc...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.